Cart
sales@molnova.com
Chrysin
CAS No. 480-40-0
Chrysin ( 5,7-Dihydroxyflavone | NSC 407436 )
Catalog No. M14603 CAS No. 480-40-0
Chrysin is mainly found in passion flowers, honey, and propolis acts as a potential therapeutic and preventive agent to inhibit proliferation and invasion of various human cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | 45 | In Stock |
|
Biological Information
-
Product NameChrysin
-
NoteResearch use only, not for human use.
-
Brief DescriptionChrysin is mainly found in passion flowers, honey, and propolis acts as a potential therapeutic and preventive agent to inhibit proliferation and invasion of various human cancer cells.
-
DescriptionChrysin is mainly found in passion flowers, honey, and propolis acts as a potential therapeutic and preventive agent to inhibit proliferation and invasion of various human cancer cells.
-
In Vitro——
-
In Vivo——
-
Synonyms5,7-Dihydroxyflavone | NSC 407436
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number480-40-0
-
Formula Weight254.24
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 51 mg/mL (200.59 mM)
-
SMILESO=C1C=C(C2=CC=CC=C2)OC3=C1C(O)=CC(O)=C3
-
Chemical Name5,7-Dihydroxy-2-phenyl-4H-chromen-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lim W, et al. Chrysin Attenuates Progression of Ovarian Cancer Cells by Regulating Signaling Cascades and Mitochondrial Dysfunction. J Cell Physiol. 2017 Aug 17.
molnova catalog
related products
-
Diethylstilbestrol
Diethylstilbestrol, a synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders.
-
Estropipate
Estropipate is a form of estrogen.
-
Camizestrant
Camizestrant (Estrogen receptor antagonist 2) is an antagonist of the estrogen receptor and can be used in studies about ER+ HER2-advanced breast cancer.
